The week in industry: Overall decline in 2019 Q3 growth for top five pharmaceutical companies
This week: Advancing hearing therapeutics with a new partnership, forwarding cannabinoid-based preclinical research through collaboration and first anti-PD-1 for non-muscle-invasive bladder cancer gains FDA approval.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>